Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 6—June 2021
Dispatch

Seroepidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Logging Communities, Myanmar

Tierra Smiley EvansComments to Author , Theingi Win Myat, Nang Sarm Hom, Keersten Michelle Ricks, Min Thein Maw, Zaw Min Oo, Aung Than Toe, Nyein Thu Aung, Pyaephyo Aung, Tin Htun Aung, Paul Kuehnert, Kyaw Zin Thant, Ye Tun Win, Wai Zin Thein, Nicole Rae Gardner, Randal Joseph Schoepp, Christine Kreuder Johnson1, and Hlaing Myat Thu1
Author affiliations: University of California, Davis, Davis, California, USA (T. Smiley Evans, A.T. Toe, N.T. Aung, N.R. Gardner, C.K. Johnson); Department of Medical Research, Yangon, Myanmar (T.W. Myat, N.S. Hom, H.M. Thu); US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA (K.M. Ricks, P. Kuehnert, R.J. Schoepp); Livestock Breeding and Veterinary Department, Yangon (M.T. Maw, Y.T. Win, W.Z. Thein); Myanmar Timber Enterprise, Yangon (Z.M. Oo); Nature Conservation Society Myanmar, Yangon (P. Aung, T.H. Aung); Myanmar Academy of Medical Science, Yangon (K.Z. Thant)

Cite This Article

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is endemic in Asia, infecting many animal hosts, but CCHFV has not been reported in Myanmar. We conducted a seroepidemiologic survey of logging communities in Myanmar and found CCHFV exposure was common (9.8%) and exposure to wild animal blood and body fluids was associated with seropositivity.

Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-Congo hemorrhagic fever virus (CCHFV) (1), is a widely distributed arboviral disease. Human CCHF cases have been reported in >30 countries in Africa, the Middle East, Asia, and southeastern Europe (2). However, clinical cases or seroprevalence studies for CCHFV have not been reported in Myanmar, likely because active surveillance in humans or animals has not been established (3).

Hyalomma ticks, 1 of several CCHFV tick family hosts, are considered the primary vector transmitting CCHFV to humans (4). Hyalomma tick distribution extends into Myanmar (5), and CCHF has been reported in the neighboring countries of China and India (6,7). Expansion of CCHF from countries with known virus circulation to neighboring countries could occur through introduction of infected ticks, human CCHF cases, or movement of animals (8). Climate change also is expected to influence the distribution of Hyalomma ticks and CCHFV infections (9), increasing the likelihood of disease expansion.

Human CCHFV infections can occur through contact with an infected tick or with blood or tissues from infected humans or animals. People living or working closely with livestock or who have heavy exposure to ticks are at increased risk for CCHFV infection (10,11). Limited investigations have been performed to identify human exposure to CCHFV caused by wild animal contact, despite serologic evidence for exposure to CCHFV in numerous vertebrate species, including birds (Galliformes and Passeriformes), wild hoof stock (Artiodactyla, Cetartiodactyla, and Perissodactyla), carnivores (Carnivora), bats (Chiroptera), hedgehogs (Erinaceomorpha), rabbits and hares (Lagomorpha), elephants (Proboscidea), rodents (Rodentia), and turtles (Testudinata) (12).

CCHF has been designated by the World Health Organization as 1 of 10 high-priority emerging infectious diseases (https://www.who.int/emergencies/diseases/2018prioritization-report.pdf). The designation was based on CCHF’s epidemic and emergence potential, a high case-fatality rate of up to 80% depending on healthcare infrastructure and CCHFV genotype, and a lack of approved medical countermeasures for CCHF (13,14). Most initial reports of CCHF cases in individual countries have been preceded by epidemiologic surveys that provided evidence of local CCHFV circulation. Our goal was to conduct targeted CCHFV surveillance of Myanmar logging communities, which contain an occupational group with expected high exposure to ticks, domestic livestock, and wild animals.

The Study

Myanmar uses a traditional method of elephant logging for timber harvest. Consequently, Myanmar has a large network of communities in which loggers live together in temporary villages with their families and occasionally migrant laborers. We collected data from 102 healthy persons from 5 elephant logging communities in and near the Yenwe Forest Reserve, a protected area in central Myanmar, during June 2016–August 2018. Most (57/102) participants, including persons from forest management, logging crews, and elephant caretakers, worked in the protected area and were exposed to forested areas and vectors associated with CCHFV (Table 1). Participants were 17–67 years of age and the median age was 32.5 years. We collected venous blood samples and quantitative medical and behavioral questionnaires from each participant (Appendix).

We used a bead-based MagPix (Luminex Corporation, https://www.luminexcorp.com) assay platform, developed at the US Army Medical Research Institute of Infectious Diseases, to detect specific IgG reactivity against the nucleoprotein of CCHFV. We used molecular detection of conserved regions of the small, medium, and large segments of bunyavirus to detect CCHFV viremia with conventional PCR (Appendix).

We identified previous CCHFV exposure among study participants, but we did not detect any active infections. Study participants did not exhibit any signs of hemorrhagic fever, and none reported having previously suffered symptoms of hemorrhagic-like illnesses. All participants tested negative for bunyaviruses by consensus PCR. Among study participants, 9.8% (10/102) were seropositive for CCHFV by MagPix IgG assay. Samples categorized as positive ranged from 1,124–8,911 mean fold increase (MFI) and a signal-to-noise ratio (S/N) of 33.8–207.8. Negative samples had an MFI of 44–854 and 1–19.9 S/N. Persons 31–40 years of age were significantly more likely to be seropositive for CCHFV (p = 0.05) compared with other age groups. We noted no statistically significant associations between specific occupations and CCHFV exposure (Table 1).

Persons who reported handling live or recently slaughtered primates (age-adjusted odds ratio [ORage adjusted] = 5.53; p = 0.020) or wild carnivores (ORage adjusted = 1.3; p = 0.004) in their lifetimes were more likely to have been exposed to CCHFV (Table 2). Handling primates was significantly correlated with handling carnivores (Pearson’s correlation = 0.6; p<0.001). Therefore, we used independent multivariable logistic regression models to adjust for age while assessing the association of CCHFV seropositivity for these 2 factors. More male than female persons reported handling primates (20 male vs. 3 female persons) and carnivores (9 male vs. 3 female persons) and their ages ranged from 19–60 years. Handling primates or carnivores was not statistically significantly associated with any occupational or other behavioral factors.

Among persons who reported handling wildlife, the highest risk species for CCHFV exposure were primates and carnivores. Although sample size for handling some live or recently slaughtered wild animal taxa were low (for instance, <5 persons each reported handling rodents or bats), we found no statistically significant association between combined wildlife taxa evaluated and CCHFV exposure (p = 1.0; Table 2).

A bite from an infected tick was not the likely route of exposure to CCHFV in this community. We evaluated occupations associated with increased forest contact, and thus tick habitat, such as resource extraction, protected area worker (forest ranger), or hunter, as a combined variable, but we found no statistically significant association between occupation and CCHFV exposure.

Contact with domestic animals also was not the likely route of CCHFV exposure in this community. Study participants were not frequently exposed to ruminants, the domestic animal group most reported as associated with CCHFV exposure in endemic countries. Participants were more likely to report contact with pigs or poultry, but these animals have not been identified as amplifying hosts for CCHFV. Contact with live or dead domestic animals of any kind was not associated with CCHFV exposure (Table 2).

Nonhuman primates have not been implicated as natural reservoir hosts or sources of human CCHFV infection. However, rhesus macaques (Macaca mulatta) and long-tailed macaques (M. fascicularis), which range throughout Myanmar, have been infected with CCHFV in laboratory settings. Rhesus macaques develop viremia without clinical signs, but long-tailed macaques develop signs of clinical illness and viremia similar to disease progression in humans (15). Contact with blood or other bodily fluids, including saliva, urine, or feces, during a period of viremia in macaques could lead to human infection. Similarly, wild carnivores have not been implicated as natural reservoir hosts for CCHFV, but red foxes (Vulpes vulpes), which are thought to range in Myanmar, and Pallas’s cats (Otocolobus manul), which range in central Asia, have demonstrated CCHFV seropositivity and could serve as sources of human infection, particularly through bushmeat hunting, which exposes persons to animal blood and body fluids.

Conclusions

Our findings indicate that CCHFV is circulating in Myanmar with human infections that are either mildly symptomatic or occurring in populations that fall outside of existing surveillance systems. Although exposure to domestic animal amplifying hosts is the most commonly reported exposure type for human CCHFV infections in endemic countries, our findings show that persons with close contact with wild animal reservoir hosts, especially blood and body fluids of nonhuman primates and carnivores, also are at risk for CCHFV infection. Surveillance of at-risk populations in Myanmar should be expanded to better prepare for potential future outbreaks of CCHF.

Dr. Smiley Evans is a research epidemiologist at the One Health Institute, University of California, Davis, California, USA. Her research focuses on disease transmission dynamics between humans and wildlife and the impact of biodiversity on disease emergence.

Top

Acknowledgments

We thank the Department of Medical Research, the Myanmar Timber Enterprise, the Livestock Breeding and Veterinary Department, and the Forest Department of the Republic of the Union of Myanmar for their support and facilitation of this research. We thank Than Toe, Than Swe, Khin Maung Win, Tin Tin Myaing, Cynthie Tin Oo, and Daniel Fishbein for their guidance on working in Myanmar.

Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under grant no. K01TW010279. C.J. and N.G. were supported by the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (cooperative agreement no. GHN-A-OO-09-00010-00). Laboratory work was funded in part by the Global Emerging Infections Surveillance (GEIS) Section of the Armed Forces Health Surveillance Branch (AFHSB) research plans (ProMIS P0141_19_RD and P0129_20_RD) through USAMRIID.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, USAID, or the US Army.

Top

References

  1. Hoogstraal  H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979;15:307417. DOIPubMed
  2. Ergönül  O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:20314. DOIPubMed
  3. Al-Abri  SS, Abaidani  IA, Fazlalipour  M, Mostafavi  E, Leblebicioglu  H, Pshenichnaya  N, et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis. 2017;58:829. DOIPubMed
  4. Maltezou  HC, Papa  A. Crimean-Congo hemorrhagic fever: risk for emergence of new endemic foci in Europe? Travel Med Infect Dis. 2010;8:13943. DOIPubMed
  5. Messina  JP, Pigott  DM, Golding  N, Duda  KA, Brownstein  JS, Weiss  DJ, et al. The global distribution of Crimean-Congo hemorrhagic fever. Trans R Soc Trop Med Hyg. 2015;109:50313. DOIPubMed
  6. Bente  DA, Forrester  NL, Watts  DM, McAuley  AJ, Whitehouse  CA, Bray  M. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100:15989. DOIPubMed
  7. Patel  AK, Patel  KK, Mehta  M, Parikh  TM, Toshniwal  H, Patel  K. First Crimean-Congo hemorrhagic fever outbreak in India. J Assoc Physicians India. 2011;59:5859.PubMed
  8. Spengler  JR, Bergeron  É, Spiropoulou  CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Curr Opin Virol. 2019;34:708. DOIPubMed
  9. Estrada-Peña  A, Sánchez  N, Estrada-Sánchez  A. An assessment of the distribution and spread of the tick Hyalomma marginatum in the western Palearctic under different climate scenarios. Vector Borne Zoonotic Dis. 2012;12:75868. DOIPubMed
  10. Vorou  R, Pierroutsakos  IN, Maltezou  HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis. 2007;20:495500. DOIPubMed
  11. Deyde  VM, Khristova  ML, Rollin  PE, Ksiazek  TG, Nichol  ST. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol. 2006;80:883442. DOIPubMed
  12. Spengler  JR, Bergeron  É, Rollin  PE. Seroepidemiological studies of Crimean-Congo hemorrhagic fever virus in domestic and wild animals. PLoS Negl Trop Dis. 2016;10:e0004210. DOIPubMed
  13. Schwarz  TF, Nsanze  H, Ameen  AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection. 1997;25:3647. DOIPubMed
  14. Leblebicioglu  H, Ozaras  R, Irmak  H, Sencan  I. Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges. Antiviral Res. 2016;126:2134. DOIPubMed
  15. Smith  DR, Shoemaker  CJ, Zeng  X, Garrison  AR, Golden  JW, Schellhase  CW, et al. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog. 2019;15:e1008050. DOIPubMed

Top

Tables

Top

Cite This Article

DOI: 10.3201/eid2706.203223

Original Publication Date: May 06, 2021

1These senior authors contributed equally to this article.

Table of Contents – Volume 27, Number 6—June 2021

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Address for Correspondence: Tierra Smiley Evans, 1089 Veterinary Medicine Dr, University of California, Davis, CA 95616, USA

Send To

10000 character(s) remaining.

Top

Page created: April 07, 2021
Page updated: May 18, 2021
Page reviewed: May 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external